New City, NY, United States of America

Jeremy Ian Levin

USPTO Granted Patents = 60 

Average Co-Inventor Count = 2.4

ph-index = 13

Forward Citations = 368(Granted Patents)

Forward Citations (Not Self Cited) = 326(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Rockland, NY (US) (1992)
  • Spring Valley, NY (US) (1988 - 1995)
  • Nannet, NY (US) (1998 - 2000)
  • Nanuet, NY (US) (1994 - 2003)
  • New City, NY (US) (2001 - 2009)

Company Filing History:


Years Active: 1988-2009

Loading Chart...
60 patents (USPTO):

Title: **The Innovative Contributions of Jeremy Ian Levin**

Introduction

Jeremy Ian Levin, based in New City, NY, is a distinguished inventor known for his impressive portfolio of 60 patents. His innovative work primarily focuses on the development of therapeutic compounds, particularly in the realm of treating diseases associated with TNF-α.

Latest Patents

Among his notable inventions are two recent patents:

1. **Beta-sulfonamide Hydroxamic Acid Inhibitors of TACE/Matrix Metalloproteinase**

This invention encompasses compounds that are effective in treating various diseases and disorders mediated by TNF-α. These conditions include rheumatoid arthritis, tumor metastasis, tissue ulceration, diabetes, multiple sclerosis, and many others. The invention not only details the structural compounds but also outlines methods for their use in alleviating symptoms associated with these conditions.

2. **Alkynyl-Containing Tryptophan Derivative Inhibitors of TACE/Matrix Metalloproteinase**

This invention presents compounds similarly aimed at addressing diseases mediated by TNF-α, providing methods for use in treatment and symptom alleviation.

Career Highlights

Jeremy has made significant contributions while working with renowned companies, including American Cyanamid Company and Wyeth Holdings Corporation. His career has been marked by a commitment to innovation, consistently pushing the boundaries of medical research and therapeutic development.

Collaborations

Throughout his career, Jeremy has collaborated with esteemed professionals, including Aranapakam Mudumbai Venkatesan and James Ming Chen. These partnerships have undoubtedly enhanced the innovative capacity of his projects, fostering an environment of collaborative research and development.

Conclusion

In summary, Jeremy Ian Levin stands out as a prominent inventor whose contributions through his extensive patent portfolio demonstrate the vital intersection of innovation and medicine. His dedication to addressing complex health issues continues to inspire advancements in therapeutic treatments and showcases the profound impact of inventive ingenuity in the healthcare field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…